In the News
Roundwood Doctor Nicola leads Hepatitis C reseach - Wicklow People
Roundwood Doctor Nicola leads Hepatitis C reseach
Wicklow People
Hepatitis C virus (HCV) is an RNA virus of the Flaviviridae family that poses a global health problem. Infection leads to progressive liver disease and has been associated with a variety of extrahepatic syndromes, including central nervous system (CNS) ...
Categories: In the News
Drug gives hope to hep C sufferers - Adelaide Now
Drug gives hope to hep C sufferers
Adelaide Now
A new drug is expected to boost the cure rate for the most common strain of hepatitis C. Source: The Courier-Mail A DRUG set to cure thousands of Australians with hepatitis has been hailed as a breakthrough. Victrelis has been approved by medicines ...
New Hep C treatment available in AustraliaHerald Sun
Hepatitis drug boost for patientsThe West Australian
Breakthrough in hepatitis treatmentThe Daily Telegraph
all 14 news articles »
Categories: In the News
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C ... - MarketWatch (press release)
Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C ...
MarketWatch (press release)
"In addition to our expansive opportunity in hepatitis C, we continue to advance parallel strategies to address HIV, cancer, and sepsis." Beyond the opportunity to improve PR standard-of-care therapy, Hemopurifier® therapy may also benefit emerging ...
and more »
Categories: In the News
Stem cells could drive hepatitis research forward - MIT News
Stem cells could drive hepatitis research forward
MIT News
Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant.
Stem Cells May Further Hepatitis C ResearchU.S. News & World Report
all 14 news articles »
Categories: In the News
Achillion, Idenix could miss hep-C merger bonanza - MarketWatch
Achillion, Idenix could miss hep-C merger bonanza
MarketWatch
By Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn't assume that an eye-popping bid for Idenix Pharmaceuticals and Achillion ...
Categories: In the News
Cell-permeable peptide that inhibits hepatitis C virus identified - TruthDive
Cell-permeable peptide that inhibits hepatitis C virus identified
TruthDive
Washington, Feb 1 (ANI): Researchers have now identified a cell-permeable peptide, which impedes a hepatitis C virus protein and blocks viral replication that can cause liver cancer and cirrhosis. This finding by Dr. Samuel French, an assistant ...
and more »
Categories: In the News
Prosecutor says doctor in hepatitis C outbreak is faking disabilities. - Las Vegas Review - Journal
Prosecutor says doctor in hepatitis C outbreak is faking disabilities.
Las Vegas Review - Journal
Desai, 62, is challenging state medical experts who found him competent to stand trial on criminal charges in the 2007 hepatitis C outbreak. » Buy this photo By Jeff German Dr. Dipak Desai, the physician at the center of the hepatitis C outbreak, ...
and more »
Categories: In the News
Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men - AIDSmeds.com HIV/AIDS Treatment News
So So Gay
Awareness, Testing Needed to Curb Hep C Infections Among HIV-Positive Gay Men
AIDSmeds.com HIV/AIDS Treatment News
A new report by the National AIDS Trust (NAT), a leading HIV organization in the United Kingdom, concludes that much more needs to be done to address the burgeoning epidemic of hepatitis C virus (HCV) infection among gay men living with HIV.
HIV's Increasingly Dangerous SidekickSo So Gay
all 2 news articles »
Categories: In the News
FDA takes action against New York cheese manufacturer
The U.S. Food and Drug Administration is asking a federal court to prevent a New York cheese manufacturer from operating because of a history of unsanitary conditions and producing cheese in a facility contaminated with Listeria monocytogenes bacteria.
Categories: In the News
New Hep C treatment available in Australia - Herald Sun
New Hep C treatment available in Australia
Herald Sun
A RECENTLY developed treatment for the most common form of hepatitis C has been approved for use in Australia by the Therapeutic Goods Administration (TGA). Victrelis, also known as boceprevir, comes from a group of drugs known as a protease inhibitors ...
New Hep C treatment in AustraliaAdelaide Now
Breakthrough in hepatitis treatmentThe Daily Telegraph
all 10 news articles »
Categories: In the News
Vertex Hep C Sales Growth Nears End - TheStreet.com
Vertex Hep C Sales Growth Nears End
TheStreet.com
(TheStreet) -- Vertex Pharmaceuticals'(VRTX) fourth-quarter earnings report Thursday may represent the high-water sales mark for the hepatitis C drug Incivek -- with prescriptions already declining just seven months after launch.
Vertex Falls as Analyst Cuts Hep C Sales Estimate: Boston MoverBusinessWeek
Vertex Falls as Analyst Cuts Sales Estimates on Hepatitis C PillBloomberg
Vertex shares drop as analyst cools on high-flying hep C drugBoston Business Journal
LocalizedUSA
all 15 news articles »
Categories: In the News
Inovio Pharmaceuticals Moves Closer to "Universal" Influenza Vaccine by ... - MarketWatch (press release)
Inovio Pharmaceuticals Moves Closer to "Universal" Influenza Vaccine by ...
MarketWatch (press release)
Inovio's clinical programs include Phase II studies for cervical dysplasia, leukemia and hepatitis C virus, and Phase I studies for influenza and HIV. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer ...
and more »
Categories: In the News
Hepatitis C cases rise in Cortland - Ithaca Journal
Hepatitis C cases rise in Cortland
Ithaca Journal
CORTLAND -- An unusually high number of hepatitis C cases have been reported in Cortland County, according to the county Health Department, which has an investigation under way with the state Health Department. The hepatitis C virus affects the liver ...
and more »
Categories: In the News
Cell Permeable Peptide Identified that Inhibits Hepititis C Replication - HealthNewsDigest.com
HealthNewsDigest.com
Cell Permeable Peptide Identified that Inhibits Hepititis C Replication
HealthNewsDigest.com
By Staff Editor (HealthNewsDigest.com) - Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and ...
UCLA researchers indentify a cell-permeable peptide that inhibits hepatitis CScience Codex
all 8 news articles »
Categories: In the News
Stem cells may shed light on hepatitis, MIT researchers find - Mass High Tech
Mass High Tech
Stem cells may shed light on hepatitis, MIT researchers find
Mass High Tech
By Lori Valigra Researchers at MIT and their colleagues said they have devised a way to produce liver-like cells from stem cells, a key step in studying why people respond differently to Hepatitis C. An infectious disease that can cause inflammation ...
Categories: In the News
Md. cop dies of Hepatitis C - Police News
W*USA 9
Md. cop dies of Hepatitis C
Police News
By PoliceOne Staff ROCKVILLE, Md. — A police officer died Friday of Hepatitis C, which he contracted after an on-duty injury. Officer Bill Talbert, 64, was struck by a drunk driver in 1980 as he stood between his cruiser and another car, ...
Montgomery County Police Officer William D. 'Bill' Talbert Dies After Long ...W*USA 9
all 3 news articles »
Categories: In the News
Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers - AIDSmeds.com HIV/AIDS Treatment News
Alcohol Treatment Boosts Hep C Cure Rates Among Drinkers
AIDSmeds.com HIV/AIDS Treatment News
People who drink—even heavily—can successfully undergo treatment for hepatitis C virus (HCV) if they're provided with individualized, multidisciplinary care that also addresses their alcohol use, according to a study published in the February 2012 ...
Categories: In the News
FDA approves new treatment for most common type of skin cancer
Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).
Categories: In the News
Hepatitis C Virus Studied as Risk Factor in Liver Cancer - Infectious Disease Special Edition
Gastroenterology & Endoscopy News
Hepatitis C Virus Studied as Risk Factor in Liver Cancer
Infectious Disease Special Edition
by George Ochoa Two Mayo Clinic studies have clarified the importance of chronic hepatitis C virus (HCV) in the rising trend of liver cancer, or hepatocellular carcinoma (HCC). One study (Yang et al. Mayo Clin Proc. 2012;87:9-16) analyzed longitudinal ...
Hepatitis C virus to hepatocellular carcinoma7thSpace Interactive (press release)
all 3 news articles »
Categories: In the News
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
The U.S. Food and Drug Administration today approved Inlyta (axitinib) to treat patients with advanced kidney cancer (renal cell carcinoma) who have not responded to another drug for this type of cancer.
Categories: In the News
© Lloyd Wright {dot} org